Actinium Pharmaceuticals, Inc. - Common Stock (ATNM)

Historical Holders from Q1 2019 to Q3 2025

Symbol: ATNM on NYSE
Type / Class: Equity / Common Stock
Shares outstanding: 31,249,203
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 5,146,844
Holdings value: $8,234,489
% of all portfolios: 0%
Number of holders: 60
Number of buys: 18
Number of sells: -36
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Actinium Pharmaceuticals, Inc. - Common Stock (ATNM)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
VANGUARD GROUP INC	4.39%		$1,920,576		1,371,840		The Vanguard Group	30 Jun 2025
BlackRock, Inc.	1.5%		$646,490		462,969		BlackRock, Inc.	30 Jun 2025

Institutional Holders of Actinium Pharmaceuticals, Inc. - Common Stock (ATNM)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	5,146,844	$8,234,489	-$424,552		$67,680	$1.6	60
2025 Q2	5,475,849	$7,665,146	-$4,035,323	$0	$54,880	$1.4	62
2025 Q1	8,198,200	$13,196,751	+$237,439	$9,982	$83,559	$1.61	69
2024 Q4	8,134,174	$10,248,048	-$913,574	$6,048	$75,096	$1.26	69
2024 Q3	8,459,139	$15,901,857	-$617,206	$40,796	$122,576	$1.88	71
2024 Q2	7,246,907	$53,627,942	+$3,426,497	$521,700	$714,840	$7.4	73
2024 Q1	6,729,352	$52,695,053	+$7,761,585	$1,161,189	$2,888,487	$7.83	65
2023 Q4	5,758,372	$29,252,507	-$58,635	$353,568	$500,380	$5.08	59
2023 Q3	5,762,849	$34,114,400	-$1,202,051	$513,856	$639,952	$5.92	58
2023 Q2	6,040,790	$44,822,973	+$8,382,914	$1,012,830	$490,462	$7.42	69
2023 Q1	4,756,784	$44,950,334	+$1,894,131	$1,349,460	$1,159,515	$9.45	65
2022 Q4	4,488,300	$47,826,517	+$17,470,046	$1,110,795	$1,565,550	$10.65	59
2022 Q3	2,863,634	$21,129,560	+$2,886,294	$477,000	$2,012,000	$7.38	46
2022 Q2	2,464,649	$11,852,572	+$2,944,615	$650,000	$1,791,000	$4.81	39
2022 Q1	1,829,833	$9,346,008	-$539,334	$411,000	$3,097,000	$5.11	32
2021 Q4	1,908,876	$11,473,412	-$433,272	$322,000	$1,301,000	$6.01	33
2021 Q3	1,932,424	$17,120,867	+$1,950,325	$729,000	$3,053,000	$8.86	39
2021 Q2	1,727,482	$13,663,637	+$3,303,864	$507,000	$1,367,000	$7.91	31
2021 Q1	1,310,290	$9,986,632	-$5,421,678	$330,000	$16,387,000	$7.62	33
2020 Q4	2,003,580	$15,628,122	-$4,777,521	$894,000	$1,367,000	$7.8	43
2020 Q3	2,385,295	$23,109,542	+$23,097,542	$329,000	$100,000	$9.69	36
2020 Q2	3,868	$13,000				$4.22	2
2020 Q1	1,498	$12,000				$8.01	1
2019 Q4	3,868	$13,000				$4.22	2
2019 Q3	1,498	$12,000				$8.01	1
2019 Q2	1,498	$12,000				$8.01	1
2019 Q1	1,498	$12,000				$8.01	1